Bradykinin B2 receptor gene polymorphism is associated with angiotensin-converting enzyme inhibitor-related cough

Hypertension

Volumn 36, Issue 1, 2000, Pages 127-131

  Mukae, Shuji ^a   Aoki, Shuichi ^a   Itoh, Seiji ^a   Iwata, Toshiki ^a   Ueda, Hiroaki ^a   Katagiri, Takashi ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bradykinin; Genes; Polymorphism; Promoter

Indexed keywords

BRADYKININ B2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; COUGHING; DNA POLYMORPHISM; ESSENTIAL HYPERTENSION; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0033858856     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.36.1.127     Document Type: Article

References (37)

1. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure: Collaborative Group on ACE Inhibitor Trials. JAMA. 1995;273:1450-1456.
2. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
3. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342:812-828.
4. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987; 316:1429-1435.
5. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC. Effects of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial: the SAVE Investigators. N Engl J Med. 1992;327:669-677.
6. Vaughan DE, Pfeffer MA. Angiotensin converting enzyme inhibitors and cardiovascular remodeling. Cardiovasc Res. 1994;28:159-165.
7. St. John Sutton M, Pfeffer MA, Plappert T, Rouleau JL, Moye LA, Dagenais GR, Lamas GA, Klein M, Sussex B, Goldman S. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. Circulation. 1994;89:68-75.
8. Andrejak M, Andrejak MT, Osterman G. Enalapril, captopril, and cough. Arch Intern Med. 1988;148:249.
9. Karpman L. Cough from ACE inhibitors. Am Heart J. 1988;116:1658.
10. McEwan JR, Choudry N, Street R, Fuller RW. Change in cough reflex after treatment with enalapril and ramipril. BMJ. 1989;299:13-16.
11. Furuya K, Yamaguchi E, Hirabayashi T, Itoh A, Hizawa N, Ohnuma N. Angiotensin-I-converting enzyme polymorphism and susceptibility to cough. Lancet. 1994;343:354.
12. Zee RYL, Rao VS, Paster RZ, Sweet CS, Lindpaintner K. Three candidate genes and angiotensin-converting enzyme inhibitor-related cough. Hypertension. 1998;31:925-928.
13. Dray A, Perkins M. Bradykinin and inflammatory pain. Trends Neurosci. 1993;16:99-104.
14. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins, kallikreins, kininogens, and kininases. Pharmacol Rev. 1992;44:1-80.
15. Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev. 1980;32:1-46.
16. Burch RM, Kyle DJ. Recent developments in the understanding of bradykinin receptors. Life Sci. 1992;50:829-838.
17. Regoli D, Rhaleb NE, Drapeau G, Dion S. Kinin receptor subtypes. J Cardiovasc Pharmacol. 1990;15(suppl 6):30-38.
18. Burch RM, Kyle DJ. Minireview: recent development in the understanding of bradykinin receptors. Life Sci. 1992;50:829-838.
19. Pesquero JB, Lindsey CJ, Zeh K, Paiva ACM, Ganten D, Bader M. Molecular structure and expression of bradykinin B2 receptor gene. J Biol Chem. 1994;269:26920-26925.
20. Eggerickx D, Raspe E, Bertrand D, Vassart G, Parmentier M. Molecular cloning, functional expression and pharmacological characterization of a human bradykinin B2 receptor gene. Biochem Biophys Res Commun. 1992;187:1306-1313.
21. Hess JF, Borkowski JA, Young GS, Strader CD, Ransom RW. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem Biophys Res Commun. 1992;184:260-268.
22. Powell SJ, Slynn G, Thomas C, Hopkins B, Briggs I, Graham A. Human bradykinin B2 receptor: nucleotide sequence analysis and assignment to chromosome 14. Genomics. 1993;15:435-438.
23. Ma JX, Wang DZ, Chao L, Chao J. Cloning, sequence analysis and expression of the gene encoding the mouse bradykinin B2 receptor. Gene. 1994;149:283-288.
24. Braun A, Kammerer S, Bohme E, Muller B, Roscher AA. Identification of polymorphic sites of the human bradykinin β2 receptor gene. Biochem Biophys Res Commun. 1995;211:234-240.
25. Kammerer S, Braun A, Arnold N, Roscher AA. The human bradykinin β2 receptor gene: full length cDNA, genomic organization and identification of the regulatory region. Biochem Biophys Res Commun. 1995;211:226-233.
26. Braun A, Kammerer S, Maier E, Bohme E, Roscher AA. Polymorphism in the gene for the human β2-bradykinin receptor: new tools assessing a genetic risk for bradykinin-associated diseases, Immunopharmacology. 1996;33:32-35.
27. Os I, Bratland B, Dahlof B, Gisholt K, Syvertsen JO, Tretli S. Cough associated with lisinopril-treatment is sex-dependent. J Hypertens. 1992; 10(suppl 4):S135. Abstract.
28. Stoller JK, Elghazawi A, Metha A, Vidt DG. Captopril-induced cough. Chest. 1988;93:659-661.
29. Erdos EG. Some old and some new ideas on kinin metabolism. J Cardiovasc Pharmacol 1990;15(suppl 6):S20-S24.
30. Morice AH, Brown MJ, Higgenbottan T. Cough associated with angiotensin converting enzyme inhibition. J Cardiovasc Pharmacol. 1989; 13(suppl 3):S59-S62.
31. Heavey DJ, Barrow SE, Hickling NE, Ritter JM. Aspirin causes short lived inhibition of bradykinin stimulated prostacyclin production in man. Nature. 1985;318:186-188.
32. Smith AP, Cuthbert MF, Dunlop LS. Cutaneous effects of inhaled prostaglandins E1, E2, and F2, alpha on the airway resistance of healthy and asthmatic men. Clin Sci. 1975;48:421-430.
33. Berkin KE. Respiratory effects of angiotensin converting enzyme inhibition. Eur Respir J. 1989;2:198-201.
34. Coleridge HM, Coleridge JC, Ginzel KH, Baker DG, Banzett RB, Morrison MA. Stimulation of 'irritant' receptors and afferent C fibres in the lungs by prostaglandins. Nature. 1976;264:451-453.
35. Nabika T, Nara Y, Yarnori Y, Lovenberg W, Endo J. Angiotensin II and phorbol ester enhance isoproterenol- and vasoactive intestinal peptide (VIP)-induced cyclic AMP accumulation in vascular smooth muscle cells. Biochem Biophys Res Commun. 1985;131:30-36.
36. Ma JX, Wang DZ, Ward C, Chen L, Dessai T, Chao J, Chao L. Structure and chromosomal localisation of the gene (BDKRB2) encoding human bradykinin B2 receptor. Genomics. 1994;23:362-369.
37. Wang DZ, Chao L, Chao J. Hypotension in transgenic mice overexpressing human bradykinin B2 receptor. Hypertension. 1997;29: 488-493.